Health Catalyst (HCAT) Stock Price
Health Catalyst Price
Revenue has compounded at 19.1% per year over the past 8 years to 286.88 M USD. Health Catalyst's net margin stands at -62.0%, up from -68.2% several years earlier. Analysts set a median price target of 2.38 USD, implying 32.7% above the current price. Of 12 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 80% above its 52-week low.
Health Catalyst stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Health Catalyst over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Health Catalyst stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Health Catalyst's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Health Catalyst Price |
|---|---|
| 9/21/2026 | 1.79 USD |
| 9/18/2026 | 1.75 USD |
| 9/17/2026 | 1.80 USD |
| 9/16/2026 | 1.73 USD |
| 9/15/2026 | 1.76 USD |
| 9/14/2026 | 1.82 USD |
| 9/13/2026 | 1.74 USD |
| 9/11/2026 | 1.70 USD |
| 9/10/2026 | 1.73 USD |
| 9/9/2026 | 1.73 USD |
| 9/8/2026 | 1.73 USD |
| 9/4/2026 | 1.69 USD |
| 9/3/2026 | 1.71 USD |
| 9/2/2026 | 1.69 USD |
| 9/1/2026 | 1.71 USD |
| 8/31/2026 | 1.64 USD |
| 8/30/2026 | 1.63 USD |
| 8/28/2026 | 1.61 USD |
| 8/27/2026 | 1.61 USD |
| 8/26/2026 | 1.59 USD |
| 8/25/2026 | 1.58 USD |
| 8/24/2026 | 1.57 USD |
| 8/21/2026 | 1.53 USD |
| 8/20/2026 | 1.63 USD |
| 8/19/2026 | 1.77 USD |
| 8/18/2026 | 1.74 USD |
| 8/17/2026 | 1.70 USD |
| 8/14/2026 | 1.85 USD |
| 8/13/2026 | 1.75 USD |
| 8/12/2026 | 1.80 USD |
Health Catalyst Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 73.00 | 112.00 | 154.00 | 188.00 | 241.00 | 276.00 | 295.00 | 306.00 | 311.00 | 247.00 | 207.00 | 225.00 |
| – | 53.42 | 37.50 | 22.08 | 28.19 | 14.52 | 6.88 | 3.73 | 1.63 | -20.58 | -16.19 | 8.70 |
| 39.73 | 46.43 | 51.30 | 47.87 | 48.55 | 48.19 | 44.41 | 45.75 | 33.44 | 33.44 | 33.44 | 33.44 |
| 29.00 | 52.00 | 79.00 | 90.00 | 117.00 | 133.00 | 131.00 | 140.00 | 104.00 | 82.60 | 69.22 | 75.24 |
| -45.00 | -60.00 | -56.00 | -96.00 | -143.00 | -140.00 | -126.00 | -69.00 | -36.00 | 10.00 | 18.00 | 21.00 |
| -61.64 | -53.57 | -36.36 | -51.06 | -59.34 | -50.72 | -42.71 | -22.55 | -11.58 | 4.05 | 8.70 | 9.33 |
| -47.00 | -61.00 | -60.00 | -115.00 | -153.00 | -137.00 | -118.00 | -69.00 | -177.00 | -3.00 | – | 6.00 |
| – | 29.79 | -1.64 | 91.67 | 33.04 | -10.46 | -13.87 | -41.53 | 156.52 | -98.31 | – | – |
| 5.00 | 27.77 | 36.52 | 42.59 | 52.12 | 54.50 | 57.48 | 62.38 | 71.00 | 71.00 | 71.00 | 71.00 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Health Catalyst generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Health Catalyst retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Health Catalyst's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Health Catalyst has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Health Catalyst's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Health Catalyst stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst business model & stock analysis
Health Catalyst SWOT Analysis
Strengths
Health Catalyst Inc. has a strong reputation in the healthcare industry, known for their data analytics solutions and expertise.
The company's software platform offers a comprehensive range of tools and features, providing advanced data-driven insights to healthcare organizations.
Health Catalyst Inc. has a talented and experienced team of data scientists and healthcare professionals, enabling them to develop innovative solutions tailored to meet the specific needs of their clients.
Weaknesses
One weakness of Health Catalyst Inc. is their relatively limited market presence compared to some larger competitors in the industry.
The company may face challenges in terms of scalability, as their solutions require significant infrastructure and resources to implement and maintain.
Health Catalyst Inc. may also struggle to keep up with the rapidly evolving technological landscape and changing healthcare regulations, which could impact the effectiveness of their solutions.
Opportunities
The increasing demand for data-driven healthcare solutions presents a significant opportunity for Health Catalyst Inc. to expand their market share and reach.
The company can leverage their expertise in data analytics to develop new products and services that cater to emerging healthcare trends and challenges.
Health Catalyst Inc. can also explore strategic partnerships and collaborations with other healthcare organizations to further enhance their offerings and broaden their customer base.
Threats
One of the major threats faced by Health Catalyst Inc. is the intense competition in the healthcare data analytics market, with numerous well-established players vying for market dominance.
Changes in healthcare policies and regulations can also pose a threat, as organizations may need to adapt or modify their software solutions to remain compliant.
Additionally, cyber threats and data breaches pose a significant risk to the company and its clients, requiring strong security measures and continuous monitoring.
Health Catalyst Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Health Catalyst Segments
Health Catalyst Revenue by Segment (1/4)
3 Years
5 Years
Max
Details
Health Catalyst Revenue by Segment (2/4)
3 Years
5 Years
Max
Details
Health Catalyst Revenue by Segment (3/4)
3 Years
5 Years
Max
Details
Health Catalyst Revenue by Segment (4/4)
3 Years
5 Years
Max
Details
Health Catalyst Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Health Catalyst historical P/E ratio, EBIT multiple, and P/S ratio
Health Catalyst annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Health Catalyst's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Health Catalyst's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Health Catalyst's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Health Catalyst shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Health Catalyst forecasts and price targets in September 2026
Analyst Price Targets 2026Health Catalyst Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 8/13/2026 | Maintained | Equal Weight | 58 | |
| 8/11/2026 | Maintained | Neutral | 46 | |
| 7/21/2026 | Maintained | Buy | 63 | |
| 6/26/2026 | Maintained | Equal Weight | 58 | |
| 5/12/2026 | Maintained | Equal Weight | 64 | |
| 3/18/2026 | Downgrade | OverweightEqual Weight | 58 | |
| 3/13/2026 | Maintained | Hold | 57 | |
| 3/13/2026 | Maintained | Equal Weight | 64 | |
| 3/13/2026 | Maintained | Neutral | 46 | |
| 3/13/2026 | Maintained | Neutral | 38 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Health Catalyst Earnings Calls
Health Catalyst Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 11/9/2026 | -0.02USD | - | 55.44 MUSD | - | 2026 Q3 |
| 8/6/2026 | 0.03USD | 0.04USD | 69.09 MUSD | - | 2026 Q2 |
| 5/11/2026 | 0.01USD | 0.02USD | 69.24 MUSD | - | 2026 Q1 |
| 3/12/2026 | 0.09USD | 0.08USD | 73.97 MUSD | - | 2025 Q4 |
| 11/10/2025 | 0.05USD | 0.06USD | 74.08 MUSD | - | 2025 Q3 |
| 8/7/2025 | 0.03USD | 0.04USD | 85.14 MUSD | - | 2025 Q2 |
| 2/26/2025 | 0.11USD | 0.04USD | 79.59 MUSD | - | 2024 Q4 |
| 11/6/2024 | 0.10USD | 0.07USD | 80.68 MUSD | - | 2024 Q3 |
| 8/7/2024 | 0.09USD | 0.12USD | 75.00 MUSD | - | 2024 Q2 |
| 5/9/2024 | 0.03USD | 0.05USD | 74.80 MUSD | - | 2024 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Health Catalyst stock
EEnvironment
Environment
SSocial
Social
GGovernance (Corporate Governance)
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Health Catalyst shareholder structure
| % | Name |
|---|---|
18.47162% | |
6.49181% | |
6.14756% | |
6.10612% | |
5.72571% | |
5.57639% |
Health Catalyst Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
18.30% | SEC ↗ | |
17.51% | SEC ↗ | |
16.14% | SEC ↗ | |
8.80% | SEC ↗ | |
8.30% | SEC ↗ | |
8.23% | SEC ↗ | |
8.07% | SEC ↗ | |
6.70% | SEC ↗ | |
6.50% | SEC ↗ | |
6.30% | SEC ↗ |
Health Catalyst Executives and Management Board
11 members · avg. age 55 · 27 % women
Mr. Benjamin Landry (43)
General Counsel, Corporate Secretary
1.57 M USD
Management
Ms. Linda Llewelyn (58)
Chief People Officer
Mr. Jason Alger (41)
Chief Financial Officer
Mr. Benjamin Albert (52)
Chief Executive Officer, Director · since 2025
Mr. Jack Knight
Vice President, Investor Relations
Board of Directors
Mr. John Kane (72)
Director
Ms. Julie Larson-Green (63)
Independent Director
Mr. Justin Spencer (53)
Chairman of the Board · since 2025
Mr. Mathew Arens
Director
Mr. Matthew Kolb (43)
Director
Dr. Jill Green (66)
Independent Director
Health Catalyst Supply Chain
Health Catalyst Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.94 | 0.41 | — | ||
| 2 | 0.91 | -0.17 | 0.11 |
Frequently asked questions about Health Catalyst
The business model of Health Catalyst Inc is focused on providing data and analytics solutions to healthcare organizations. The company aims to enable these organizations in improving patient outcomes, reducing costs, and enhancing operational efficiency by leveraging their vast amount of healthcare data. Health Catalyst offers a comprehensive suite of products and services, including a data platform, analytics applications, and expertise in areas such as quality measures, population health management, and care coordination. By utilizing advanced data analytics, Health Catalyst assists healthcare organizations in making informed decisions, identifying areas for improvement, and ultimately transforming the way healthcare is delivered.
Health Catalyst Inc is primarily active in the healthcare industry.
Some of the main competitors of Health Catalyst Inc in the market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, and McKesson Corporation.
Health Catalyst Inc is a leading provider of data and analytics in the healthcare industry. Founded in 2008, the company has quickly gained prominence for its innovative approach to improving healthcare outcomes through data-driven insights. Health Catalyst offers a comprehensive suite of solutions designed to help healthcare organizations organize, analyze, and leverage their data to drive decision-making and improve patient care. With a strong focus on value-based care and population health management, Health Catalyst has established itself as a trusted partner for healthcare organizations seeking to transform their operations and achieve better patient outcomes.
Health Catalyst Inc, a leading healthcare analytics and data warehousing company, has achieved several significant milestones. Notably, the company successfully completed its initial public offering in July 2019, raising approximately $182 million. In 2020, Health Catalyst was named one of the Best Places to Work in Healthcare by Modern Healthcare. Furthermore, the company has consistently expanded its customer base, delivering data-driven solutions to over 150 healthcare organizations. Health Catalyst's innovative use of artificial intelligence and machine learning technologies has also gained recognition, contributing to the company's growth and success in improving healthcare outcomes.
Health Catalyst Inc is primarily present in the United States.
Health Catalyst Inc is a leading provider of data and analytics solutions for healthcare organizations. The company represents values such as innovation, collaboration, and a patient-centric approach. With a focus on improving healthcare outcomes, Health Catalyst Inc emphasizes the importance of data-driven decision-making and empowering healthcare professionals with actionable insights. Their corporate philosophy revolves around driving meaningful change in the healthcare industry through leveraging advanced analytics and technology. By offering transformative solutions, Health Catalyst Inc aims to enable healthcare organizations to deliver better patient care, reduce costs, and enhance operational efficiency.
Analysts currently set an average price target of 2.38 USD for the Health Catalyst stock (median: 2.38 USD), implying +35.6 % versus the latest price. The consensus is based on 12 analyst ratings.
12 analysts currently rate the Health Catalyst stock: 6 recommend buying, 6 holding and 0 selling. For 2026, analysts expect Health Catalyst to generate revenue of 247.73 M USD and earnings per share of -0.05 USD.
Converted at the current exchange rate, the Health Catalyst share trades at 1.56 EUR (1.79 USD).
The Health Catalyst share (HCAT) is listed on 2 stock exchanges, including: NASDAQ (HCAT), Frankfurt (2YP.F).
Health Catalyst Inc is a US-based company specializing in the development of clinical analytics platforms. The company offers solutions for healthcare data analysis and data-driven decision support. Its business model is based on providing software and analytics tools to manage, integrate, analyze, and visualize clinical data. By combining the latest technologies in data analytics and business intelligence with deep expertise in healthcare, Health Catalyst supports hospitals and health systems in improving patient care. The company consists of two main divisions: data warehousing and analytics. The data warehousing division involves developing and managing databases and integrating data from various sources to obtain a comprehensive view of a facility's clinical performance and enable informed decision-making. The analytics division focuses on implementing analytics tools and methods to analyze the collected data and transform it into meaningful insights. Health Catalyst's product range includes solutions for population health management, improving clinical outcomes, and reducing healthcare costs. This includes clinical analytics and visualization tools, population health management platforms, data integration and storage solutions, and healthcare analytics services. The Health Catalyst data platform is an open system capable of processing both structured and unstructured data in real-time. This allows customers to easily integrate and analyze their data for informed decision-making. The target customers of Health Catalyst are hospitals and health systems in the United States facing increasing competitive pressure and growing demand for high-quality patient care. The company addresses the need to reduce healthcare costs, improve patient care, and optimize health processes. Health Catalyst's business model relies on recurring revenue from selling subscriptions to use the software platform and providing analytics tools and services. Additionally, the company offers training, consulting services, and technical support. In summary, Health Catalyst creates value for its customers by providing advanced tools to improve healthcare and achieve cost savings. The company's business model is also focused on recurring subscription revenue and additional service fees. By focusing on improving clinical outcomes, Health Catalyst demonstrates enthusiasm for healthcare and a passionate commitment to enhancing patient well-being.
The expected revenue of Health Catalyst is 247.73 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Health Catalyst is -3.22 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Health Catalyst is currently -39.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Health Catalyst stock.
The price-to-sales ratio (P/S) of Health Catalyst is currently 0.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Health Catalyst stock.
The Eulerpool Quality Score for Health Catalyst is 2/10.
The ISIN of Health Catalyst is US42225T1079. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Health Catalyst is A2PH3J. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Health Catalyst is HCAT. The ticker symbol is used to trade Health Catalyst shares on the stock exchange.
Health Catalyst paid dividends every year for the past 0 years.
Health Catalyst is assigned to the 'Health' sector.
The dividends of Health Catalyst are distributed in USD.
Health Catalyst stock
Health Catalyst Peer Group
Health Catalyst Ticker
Health Catalyst FIGI
All fundamentals and in-depth analysis of Health Catalyst
Our stock analysis for Health Catalyst stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Catalyst. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.